DKN-01 in combination with pembrolizumab in patients with advanced gastroesophageal adenocarcinoma (GEA): Tumoral DKK1 expression as a predictor of response and survival
Publication
, Conference
Klempner, SJ; Bendell, JC; Villaflor, VM; Tenner, LL; Stein, S; Naik, GS; Sirard, CA; Kagey, M; Chaney, MF; Strickler, JH
Published in: JOURNAL OF CLINICAL ONCOLOGY
2020
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2020
Volume
38
Issue
4
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Klempner, S. J., Bendell, J. C., Villaflor, V. M., Tenner, L. L., Stein, S., Naik, G. S., … Strickler, J. H. (2020). DKN-01 in combination with pembrolizumab in patients with advanced gastroesophageal adenocarcinoma (GEA): Tumoral DKK1 expression as a predictor of response and survival. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 38).
Klempner, Samuel J., Johanna C. Bendell, Victoria Meucci Villaflor, Laura LaNiel Tenner, Stacey Stein, Girish S. Naik, Cynthia A. Sirard, Michael Kagey, Marya F. Chaney, and John H. Strickler. “DKN-01 in combination with pembrolizumab in patients with advanced gastroesophageal adenocarcinoma (GEA): Tumoral DKK1 expression as a predictor of response and survival.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 38, 2020.
Klempner SJ, Bendell JC, Villaflor VM, Tenner LL, Stein S, Naik GS, et al. DKN-01 in combination with pembrolizumab in patients with advanced gastroesophageal adenocarcinoma (GEA): Tumoral DKK1 expression as a predictor of response and survival. In: JOURNAL OF CLINICAL ONCOLOGY. 2020.
Klempner, Samuel J., et al. “DKN-01 in combination with pembrolizumab in patients with advanced gastroesophageal adenocarcinoma (GEA): Tumoral DKK1 expression as a predictor of response and survival.” JOURNAL OF CLINICAL ONCOLOGY, vol. 38, no. 4, 2020.
Klempner SJ, Bendell JC, Villaflor VM, Tenner LL, Stein S, Naik GS, Sirard CA, Kagey M, Chaney MF, Strickler JH. DKN-01 in combination with pembrolizumab in patients with advanced gastroesophageal adenocarcinoma (GEA): Tumoral DKK1 expression as a predictor of response and survival. JOURNAL OF CLINICAL ONCOLOGY. 2020.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2020
Volume
38
Issue
4
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences